The behavioral, respiratory and cardiovascular effects of four analgesic antagonists derived from the benzomorphan nucleus have been described. In addition, the ability of these agents to reverse the respiratory, cardiovascular and behavioral depression produced by morphine and meperidine has been reported.
Two of the compounds, 2-allyl-5-ethyl-2′-hydroxy-9-methyl-6,7-benzomorphan (I) and 2-cyclopropylmethyl-2′-hydroxy-5,9-dimethyl-6,7-benzomorphan (IV) proved to be potent antagonists.
The other two, 2-(3,3-dimethylallyl)-2′-hydroxy-5,9-dimethyl-6,7-benzomorphan (II) and 2-(3,3-dimethylallyl)-5-ethyl-2′-hydroxy-9-methyl-6,7-benzomorphan (III), were found to be weak antagonists.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Archer, S., N. F. Albertson, L. S. Harris, A. K. Pierson, J. G. Bird, A. S. Keats, J. Telford, and C. N. Papadopoulous: Narcotic antagonists as analgesics. Science 137, 541 (1962).
DeKornfeld, T. J., and L. Lasagna: WIN 20, 740, a potent new analgesic agent. Fed. Proc. 22, 248 (1963).
Deneau, G. A., and M. H. Seevers: Evaluation of morphine-like physical dependence in the rhesus monkey (macaca mulatta). Addendum 2, Bull. Drug Addiction and Narcotics 1962.
Fraser, H. F., and D. E. Rosenberg: Low addictiveness of two analgesics in the benzomorphan series. Biochem. Pharmacol. Vol. 12, Supplement p. 6 (1963).
Studies on the human addiction liability of 2′-hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan (Win 20, 228): a weak narcotic antagonist. J. Pharmacol. exp. Ther. 143, 149 (1964).
Harris, L. S., and A. K. Pierson: Some narcotic antagonists in the benzomorphan series. Addendum 1, Bull. Drug Addiction and Narcotics 1962.
Some narcotic antagonists in the benzomorphan series. J. Pharmacol. exp. Ther. 143, 141 (1964).
Isbell, H.: Attempted addiction to nalorphine. Fed. Proc. 15, 442 (1956).
Keats, A. S., and J. Telford: Nalorphine, a potent analgesic in man. J. Pharmacol. exp. Ther. 117, 190 (1956).
Studies of analgetic drugs: VIII. a narcotic antagonist analgesic without psychotomimetic effects. J. Pharmacol. exp. Ther. 143, 157 (1964).
Lasagna, L., and H. K. Beecher: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. exp. Ther. 112, 356 (1954).
Telford, J., and A. S. Keats: Narcotic-narcotic antagonist mixtures. Anesthesiology 22, 465 (1961).
Unna, K.: Antagonistic effect of N-allyl-normorphine upon morphine. J. Pharmacol. exp. Ther. 79, 27 (1943).
Vivante, A., F. F. Kao, and J. Belford: The effect of nalorphine on the respiration of dogs anesthetized with pentobarbital sodium. J. Pharmacol. exp. Ther. 111, 436 (1954).
Dedicated to Professor Otto Krayer on his 65th birthday.
With 2 Figures in the Text
About this article
Cite this article
Harris, L.S. Narcotic antagonists in the benzomorphan series. Naunyn-Schmiedebergs Arch 248, 426–436 (1964). https://doi.org/10.1007/BF00246889
- Cardiovascular Effect
- Potent Antagonist